The MAA will be reviewed under the EMA's Accelerated Assessment program. Source: BioSpace

Moderna CEO said the company was not likely to float its initial public offering until the company has solid data on its lead mRNA treatment. Source: BioSpace

A little more than one year after securing $130M in financing, molecular technology company Zymergen has expanded beyond the Golden State to the Emerald City, Seattle. Source: BioSpace

Physicians collaborating with Retrotope previously received approval from the FDA to test RT001 in Expanded Access trials of two patients having Infantile Neuroaxonal Dystrophy. Source: BioSpace

For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research. Source: BioSpace

Aisling Capital today announced the closing of its newest fund, with $280M in committed capital. Source: BioSpace

Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases. Source: BioSpace

Despite Brandicourt's positive spin, investors were displeased as the company's financial report fell shy of analysts' expectations. Source: BioSpace

As part of strategic restructuring, Proteostatis is laying off 46 percent of its R&D workforce, or 13 positions. Source: BioSpace

The company submitted 15 abstracts to be presented at the upcoming ASH Conference. Source: BioSpace